June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

Constellation raises close to $200M
Cancer epigenetics company Constellation Pharmaceuticals Inc. (NASDAQ:CNST) raised $192.5 million in a bumped-up follow-on Tuesday through the sale of 5.5 million shares at $35. The price is a 7% discount to its

Read the full 364 word article

How to gain access

Continue reading with a
two-week free trial.